APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Software

Compare research editions
View pricing & licenses

Selected research

Industry Research

Decentralized Clinical Trial Software Industry Research Report 2026

Report ID 17411325052 May 2026138 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Software Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Decentralized Clinical Trial Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Decentralized Clinical Trial Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Decentralized Clinical Trial Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Decentralized Clinical Trial Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Decentralized Clinical Trial Software include Medrio, Medable, TCS, Castor EDC, THREAD, ObvioHealth, Power, Veeva and SAHMRI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Decentralized Clinical Trial Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Decentralized Clinical Trial Software.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Decentralized Clinical Trial Software Market by Company

Medrio

Medable

TCS

Castor EDC

THREAD

ObvioHealth

Power

Veeva

SAHMRI

IMI CARE

DNDi

Clario

Castor

Curebase

Infiuss

AGILE

OpenClinica

ClinCapture

DFdiscover

ClinPlus CTMS

Dacima Clinical Suite

Smartsheet

Snappii

RealTime-CTMS

Decentralized Clinical Trial Software Segment by Type

Web-based

Cloud-based

Decentralized Clinical Trial Software Segment by Application

Medical Device & Diagnostics

Biotech & Pharma

Contract Research Organizations

Academic Research

Others

Decentralized Clinical Trial Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Decentralized Clinical Trial Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Decentralized Clinical Trial Software Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Decentralized Clinical Trial Software Revenue Market Share by Type (2021-2026) Table 7. Global Decentralized Clinical Trial Software Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Decentralized Clinical Trial Software Revenue Market Share by Type (2027-2032) Table 9. Global Decentralized Clinical Trial Software Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Decentralized Clinical Trial Software Revenue Market Share by Application (2021-2026) Table 11. Global Decentralized Clinical Trial Software Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Decentralized Clinical Trial Software Revenue Market Share by Application (2027-2032) Table 13. Global Decentralized Clinical Trial Software Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Decentralized Clinical Trial Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Decentralized Clinical Trial Software Market Share by Region (2021-2026) Table 16. Global Decentralized Clinical Trial Software Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Decentralized Clinical Trial Software Market Share by Region (2027-2032) Table 18. Decentralized Clinical Trial Software Industry Trends Table 19. Decentralized Clinical Trial Software Industry Drivers Table 20. Decentralized Clinical Trial Software Industry Opportunities and Challenges Table 21. Decentralized Clinical Trial Software Market Restraints Table 22. Global Top Decentralized Clinical Trial Software Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Decentralized Clinical Trial Software Revenue Market Share by Players (2021-2026) Table 24. Global Decentralized Clinical Trial Software Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Decentralized Clinical Trial Software, Headquarters and Area Served Table 26. Global Decentralized Clinical Trial Software Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Decentralized Clinical Trial Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Decentralized Clinical Trial Software Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Decentralized Clinical Trial Software Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Decentralized Clinical Trial Software Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Decentralized Clinical Trial Software Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Decentralized Clinical Trial Software Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2027-2032) & (US$ Million) Table 45. Medrio Company Information Table 46. Medrio Business Overview Table 47. Medrio Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 48. Medrio Decentralized Clinical Trial Software Product Portfolio Table 49. Medrio Recent Developments Table 50. Medable Company Information Table 51. Medable Business Overview Table 52. Medable Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 53. Medable Decentralized Clinical Trial Software Product Portfolio Table 54. Medable Recent Developments Table 55. TCS Company Information Table 56. TCS Business Overview Table 57. TCS Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 58. TCS Decentralized Clinical Trial Software Product Portfolio Table 59. TCS Recent Developments Table 60. Castor EDC Company Information Table 61. Castor EDC Business Overview Table 62. Castor EDC Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 63. Castor EDC Decentralized Clinical Trial Software Product Portfolio Table 64. Castor EDC Recent Developments Table 65. THREAD Company Information Table 66. THREAD Business Overview Table 67. THREAD Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 68. THREAD Decentralized Clinical Trial Software Product Portfolio Table 69. THREAD Recent Developments Table 70. ObvioHealth Company Information Table 71. ObvioHealth Business Overview Table 72. ObvioHealth Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 73. ObvioHealth Decentralized Clinical Trial Software Product Portfolio Table 74. ObvioHealth Recent Developments Table 75. Power Company Information Table 76. Power Business Overview Table 77. Power Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 78. Power Decentralized Clinical Trial Software Product Portfolio Table 79. Power Recent Developments Table 80. Veeva Company Information Table 81. Veeva Business Overview Table 82. Veeva Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 83. Veeva Decentralized Clinical Trial Software Product Portfolio Table 84. Veeva Recent Developments Table 85. SAHMRI Company Information Table 86. SAHMRI Business Overview Table 87. SAHMRI Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 88. SAHMRI Decentralized Clinical Trial Software Product Portfolio Table 89. SAHMRI Recent Developments Table 90. IMI CARE Company Information Table 91. IMI CARE Business Overview Table 92. IMI CARE Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 93. IMI CARE Decentralized Clinical Trial Software Product Portfolio Table 94. IMI CARE Recent Developments Table 95. DNDi Company Information Table 96. DNDi Business Overview Table 97. DNDi Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 98. DNDi Decentralized Clinical Trial Software Product Portfolio Table 99. DNDi Recent Developments Table 100. Clario Company Information Table 101. Clario Business Overview Table 102. Clario Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 103. Clario Decentralized Clinical Trial Software Product Portfolio Table 104. Clario Recent Developments Table 105. Castor Company Information Table 106. Castor Business Overview Table 107. Castor Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 108. Castor Decentralized Clinical Trial Software Product Portfolio Table 109. Castor Recent Developments Table 110. Curebase Company Information Table 111. Curebase Business Overview Table 112. Curebase Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 113. Curebase Decentralized Clinical Trial Software Product Portfolio Table 114. Curebase Recent Developments Table 115. Infiuss Company Information Table 116. Infiuss Business Overview Table 117. Infiuss Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 118. Infiuss Decentralized Clinical Trial Software Product Portfolio Table 119. Infiuss Recent Developments Table 120. AGILE Company Information Table 121. AGILE Business Overview Table 122. AGILE Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 123. AGILE Decentralized Clinical Trial Software Product Portfolio Table 124. AGILE Recent Developments Table 125. OpenClinica Company Information Table 126. OpenClinica Business Overview Table 127. OpenClinica Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 128. OpenClinica Decentralized Clinical Trial Software Product Portfolio Table 129. OpenClinica Recent Developments Table 130. ClinCapture Company Information Table 131. ClinCapture Business Overview Table 132. ClinCapture Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 133. ClinCapture Decentralized Clinical Trial Software Product Portfolio Table 134. ClinCapture Recent Developments Table 135. DFdiscover Company Information Table 136. DFdiscover Business Overview Table 137. DFdiscover Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 138. DFdiscover Decentralized Clinical Trial Software Product Portfolio Table 139. DFdiscover Recent Developments Table 140. ClinPlus CTMS Company Information Table 141. ClinPlus CTMS Business Overview Table 142. ClinPlus CTMS Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 143. ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio Table 144. ClinPlus CTMS Recent Developments Table 145. Dacima Clinical Suite Company Information Table 146. Dacima Clinical Suite Business Overview Table 147. Dacima Clinical Suite Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 148. Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio Table 149. Dacima Clinical Suite Recent Developments Table 150. Smartsheet Company Information Table 151. Smartsheet Business Overview Table 152. Smartsheet Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 153. Smartsheet Decentralized Clinical Trial Software Product Portfolio Table 154. Smartsheet Recent Developments Table 155. Snappii Company Information Table 156. Snappii Business Overview Table 157. Snappii Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 158. Snappii Decentralized Clinical Trial Software Product Portfolio Table 159. Snappii Recent Developments Table 160. RealTime-CTMS Company Information Table 161. RealTime-CTMS Business Overview Table 162. RealTime-CTMS Revenue in Decentralized Clinical Trial Software Business (2021-2026) & (US$ Million) Table 163. RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio Table 164. RealTime-CTMS Recent Developments Table 165. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Decentralized Clinical Trial Software Product Image Figure 5. Global Decentralized Clinical Trial Software Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Decentralized Clinical Trial Software Market Share by Type: 2025 VS 2032 Figure 7. Web-based Product Figure 8. Cloud-based Product Figure 9. Global Decentralized Clinical Trial Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Decentralized Clinical Trial Software Market Share by Application: 2025 VS 2032 Figure 11. Medical Device & Diagnostics Product Figure 12. Biotech & Pharma Product Figure 13. Contract Research Organizations Product Figure 14. Academic Research Product Figure 15. Others Product Figure 16. Global Decentralized Clinical Trial Software Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Decentralized Clinical Trial Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Decentralized Clinical Trial Software Market Share by Region: 2025 VS 2032 Figure 19. Global Decentralized Clinical Trial Software Market Share by Players in 2025 Figure 20. Global Decentralized Clinical Trial Software Manufacturers Established Date Figure 21. Global Top 5 and 10 Decentralized Clinical Trial Software Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 25. United States Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 28. Europe Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 30. Germany Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 40. China Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 45. Australia Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 50. Brazil Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Decentralized Clinical Trial Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Medrio Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 56. Medable Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 57. TCS Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 58. Castor EDC Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 59. THREAD Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 60. ObvioHealth Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 61. Power Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 62. Veeva Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 63. SAHMRI Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 64. IMI CARE Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 65. DNDi Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 66. Clario Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 67. Castor Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 68. Curebase Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 69. Infiuss Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 70. AGILE Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 71. OpenClinica Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 72. ClinCapture Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 73. DFdiscover Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 74. ClinPlus CTMS Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 75. Dacima Clinical Suite Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 76. Smartsheet Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 77. Snappii Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026) Figure 78. RealTime-CTMS Revenue Growth Rate in Decentralized Clinical Trial Software Business (2021-2026)

Scope & coverage.

Types
  • Web-based
  • Cloud-based
Applications
  • Medical Device & Diagnostics
  • Biotech & Pharma
  • Contract Research Organizations
  • Academic Research
  • Others
Companies covered
  • Medrio
  • Medable
  • TCS
  • Castor EDC
  • THREAD
  • ObvioHealth
  • Power
  • Veeva
  • SAHMRI
  • IMI CARE
  • DNDi
  • Clario
  • Castor
  • Curebase
  • Infiuss
  • AGILE
  • OpenClinica
  • ClinCapture
  • DFdiscover
  • ClinPlus CTMS
  • Dacima Clinical Suite
  • Smartsheet
  • Snappii
  • RealTime-CTMS

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Decentralized Clinical Trial Software by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Web-based
  5. 2.2.3 Cloud-based
  6. 2.3 Decentralized Clinical Trial Software by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Medical Device & Diagnostics
  9. 2.3.3 Biotech & Pharma
  10. 2.3.4 Contract Research Organizations
  11. 2.3.5 Academic Research
  12. 2.3.6 Others
  13. 2.4 Assumptions and Limitations
3 Decentralized Clinical Trial Software Breakdown Data by Type
  1. 3.1 Global Decentralized Clinical Trial Software Historic Market Size by Type (2021-2026)
  2. 3.2 Global Decentralized Clinical Trial Software Forecasted Market Size by Type (2027-2032)
4 Decentralized Clinical Trial Software Breakdown Data by Application
  1. 4.1 Global Decentralized Clinical Trial Software Historic Market Size by Application (2021-2026)
  2. 4.2 Global Decentralized Clinical Trial Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Decentralized Clinical Trial Software Market Perspective (2021-2032)
  2. 5.2 Global Decentralized Clinical Trial Software Growth Trends by Region
  3. 5.2.1 Global Decentralized Clinical Trial Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Decentralized Clinical Trial Software Historic Market Size by Region (2021-2026)
  5. 5.2.3 Decentralized Clinical Trial Software Forecasted Market Size by Region (2027-2032)
  6. 5.3 Decentralized Clinical Trial Software Market Dynamics
  7. 5.3.1 Decentralized Clinical Trial Software Industry Trends
  8. 5.3.2 Decentralized Clinical Trial Software Market Drivers
  9. 5.3.3 Decentralized Clinical Trial Software Market Challenges
  10. 5.3.4 Decentralized Clinical Trial Software Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Decentralized Clinical Trial Software Players by Revenue
  2. 6.1.1 Global Top Decentralized Clinical Trial Software Players by Revenue (2021-2026)
  3. 6.1.2 Global Decentralized Clinical Trial Software Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Decentralized Clinical Trial Software Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Decentralized Clinical Trial Software Head Office and Area Served
  6. 6.4 Global Decentralized Clinical Trial Software Players, Product Type & Application
  7. 6.5 Global Decentralized Clinical Trial Software Manufacturers Established Date
  8. 6.6 Global Decentralized Clinical Trial Software Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Decentralized Clinical Trial Software Market Size (2021-2032)
  2. 7.2 North America Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  4. 7.4 North America Decentralized Clinical Trial Software Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Decentralized Clinical Trial Software Market Size (2021-2032)
  2. 8.2 Europe Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  4. 8.4 Europe Decentralized Clinical Trial Software Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Decentralized Clinical Trial Software Market Size (2021-2032)
  2. 9.2 Asia-Pacific Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Decentralized Clinical Trial Software Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Decentralized Clinical Trial Software Market Size (2021-2032)
  2. 10.2 South America Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  4. 10.4 South America Decentralized Clinical Trial Software Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Decentralized Clinical Trial Software Market Size (2021-2032)
  2. 11.2 Middle East & Africa Decentralized Clinical Trial Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Medrio
  2. 12.1.1 Medrio Company Information
  3. 12.1.2 Medrio Business Overview
  4. 12.1.3 Medrio Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  5. 12.1.4 Medrio Decentralized Clinical Trial Software Product Portfolio
  6. 12.1.5 Medrio Recent Developments
  7. 12.2 Medable
  8. 12.2.1 Medable Company Information
  9. 12.2.2 Medable Business Overview
  10. 12.2.3 Medable Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  11. 12.2.4 Medable Decentralized Clinical Trial Software Product Portfolio
  12. 12.2.5 Medable Recent Developments
  13. 12.3 TCS
  14. 12.3.1 TCS Company Information
  15. 12.3.2 TCS Business Overview
  16. 12.3.3 TCS Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  17. 12.3.4 TCS Decentralized Clinical Trial Software Product Portfolio
  18. 12.3.5 TCS Recent Developments
  19. 12.4 Castor EDC
  20. 12.4.1 Castor EDC Company Information
  21. 12.4.2 Castor EDC Business Overview
  22. 12.4.3 Castor EDC Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  23. 12.4.4 Castor EDC Decentralized Clinical Trial Software Product Portfolio
  24. 12.4.5 Castor EDC Recent Developments
  25. 12.5 THREAD
  26. 12.5.1 THREAD Company Information
  27. 12.5.2 THREAD Business Overview
  28. 12.5.3 THREAD Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  29. 12.5.4 THREAD Decentralized Clinical Trial Software Product Portfolio
  30. 12.5.5 THREAD Recent Developments
  31. 12.6 ObvioHealth
  32. 12.6.1 ObvioHealth Company Information
  33. 12.6.2 ObvioHealth Business Overview
  34. 12.6.3 ObvioHealth Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  35. 12.6.4 ObvioHealth Decentralized Clinical Trial Software Product Portfolio
  36. 12.6.5 ObvioHealth Recent Developments
  37. 12.7 Power
  38. 12.7.1 Power Company Information
  39. 12.7.2 Power Business Overview
  40. 12.7.3 Power Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  41. 12.7.4 Power Decentralized Clinical Trial Software Product Portfolio
  42. 12.7.5 Power Recent Developments
  43. 12.8 Veeva
  44. 12.8.1 Veeva Company Information
  45. 12.8.2 Veeva Business Overview
  46. 12.8.3 Veeva Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  47. 12.8.4 Veeva Decentralized Clinical Trial Software Product Portfolio
  48. 12.8.5 Veeva Recent Developments
  49. 12.9 SAHMRI
  50. 12.9.1 SAHMRI Company Information
  51. 12.9.2 SAHMRI Business Overview
  52. 12.9.3 SAHMRI Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  53. 12.9.4 SAHMRI Decentralized Clinical Trial Software Product Portfolio
  54. 12.9.5 SAHMRI Recent Developments
  55. 12.10 IMI CARE
  56. 12.10.1 IMI CARE Company Information
  57. 12.10.2 IMI CARE Business Overview
  58. 12.10.3 IMI CARE Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  59. 12.10.4 IMI CARE Decentralized Clinical Trial Software Product Portfolio
  60. 12.10.5 IMI CARE Recent Developments
  61. 12.11 DNDi
  62. 12.11.1 DNDi Company Information
  63. 12.11.2 DNDi Business Overview
  64. 12.11.3 DNDi Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  65. 12.11.4 DNDi Decentralized Clinical Trial Software Product Portfolio
  66. 12.11.5 DNDi Recent Developments
  67. 12.12 Clario
  68. 12.12.1 Clario Company Information
  69. 12.12.2 Clario Business Overview
  70. 12.12.3 Clario Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  71. 12.12.4 Clario Decentralized Clinical Trial Software Product Portfolio
  72. 12.12.5 Clario Recent Developments
  73. 12.13 Castor
  74. 12.13.1 Castor Company Information
  75. 12.13.2 Castor Business Overview
  76. 12.13.3 Castor Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  77. 12.13.4 Castor Decentralized Clinical Trial Software Product Portfolio
  78. 12.13.5 Castor Recent Developments
  79. 12.14 Curebase
  80. 12.14.1 Curebase Company Information
  81. 12.14.2 Curebase Business Overview
  82. 12.14.3 Curebase Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  83. 12.14.4 Curebase Decentralized Clinical Trial Software Product Portfolio
  84. 12.14.5 Curebase Recent Developments
  85. 12.15 Infiuss
  86. 12.15.1 Infiuss Company Information
  87. 12.15.2 Infiuss Business Overview
  88. 12.15.3 Infiuss Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  89. 12.15.4 Infiuss Decentralized Clinical Trial Software Product Portfolio
  90. 12.15.5 Infiuss Recent Developments
  91. 12.16 AGILE
  92. 12.16.1 AGILE Company Information
  93. 12.16.2 AGILE Business Overview
  94. 12.16.3 AGILE Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  95. 12.16.4 AGILE Decentralized Clinical Trial Software Product Portfolio
  96. 12.16.5 AGILE Recent Developments
  97. 12.17 OpenClinica
  98. 12.17.1 OpenClinica Company Information
  99. 12.17.2 OpenClinica Business Overview
  100. 12.17.3 OpenClinica Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  101. 12.17.4 OpenClinica Decentralized Clinical Trial Software Product Portfolio
  102. 12.17.5 OpenClinica Recent Developments
  103. 12.18 ClinCapture
  104. 12.18.1 ClinCapture Company Information
  105. 12.18.2 ClinCapture Business Overview
  106. 12.18.3 ClinCapture Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  107. 12.18.4 ClinCapture Decentralized Clinical Trial Software Product Portfolio
  108. 12.18.5 ClinCapture Recent Developments
  109. 12.19 DFdiscover
  110. 12.19.1 DFdiscover Company Information
  111. 12.19.2 DFdiscover Business Overview
  112. 12.19.3 DFdiscover Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  113. 12.19.4 DFdiscover Decentralized Clinical Trial Software Product Portfolio
  114. 12.19.5 DFdiscover Recent Developments
  115. 12.20 ClinPlus CTMS
  116. 12.20.1 ClinPlus CTMS Company Information
  117. 12.20.2 ClinPlus CTMS Business Overview
  118. 12.20.3 ClinPlus CTMS Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  119. 12.20.4 ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio
  120. 12.20.5 ClinPlus CTMS Recent Developments
  121. 12.21 Dacima Clinical Suite
  122. 12.21.1 Dacima Clinical Suite Company Information
  123. 12.21.2 Dacima Clinical Suite Business Overview
  124. 12.21.3 Dacima Clinical Suite Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  125. 12.21.4 Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio
  126. 12.21.5 Dacima Clinical Suite Recent Developments
  127. 12.22 Smartsheet
  128. 12.22.1 Smartsheet Company Information
  129. 12.22.2 Smartsheet Business Overview
  130. 12.22.3 Smartsheet Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  131. 12.22.4 Smartsheet Decentralized Clinical Trial Software Product Portfolio
  132. 12.22.5 Smartsheet Recent Developments
  133. 12.23 Snappii
  134. 12.23.1 Snappii Company Information
  135. 12.23.2 Snappii Business Overview
  136. 12.23.3 Snappii Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  137. 12.23.4 Snappii Decentralized Clinical Trial Software Product Portfolio
  138. 12.23.5 Snappii Recent Developments
  139. 12.24 RealTime-CTMS
  140. 12.24.1 RealTime-CTMS Company Information
  141. 12.24.2 RealTime-CTMS Business Overview
  142. 12.24.3 RealTime-CTMS Revenue in Decentralized Clinical Trial Software Business (2021-2026)
  143. 12.24.4 RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio
  144. 12.24.5 RealTime-CTMS Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst